BAG‐1 expression in human breast cancer: interrelationship between BAG‐1 RNA, protein, HSC70 expression and clinico‐pathological data
- 10 April 2002
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 197 (1) , 51-59
Abstract
BAG‐1 (BCL‐2 athanogene‐1), a multifunctional protein which associates with steroid hormone receptors (including the oestrogen receptor) and the anti‐apoptotic BCL‐2 protein, regulates steroid hormone‐dependent transcription and apoptosis. Direct interaction with 70 kD heat‐shock proteins, HSC70 and HSP70, may mediate the diverse functions of BAG‐1. Immunohistochemistry was used to examine the expression of BAG‐1 and HSC70 in 160 cases of invasive breast cancer. BAG‐1 was expressed in 92% of cases; most tumours exhibited cytoplasmic BAG‐1, while a smaller proportion also had nuclear immunostaining. There was a significant inverse correlation between histological grade and nuclear BAG‐1 expression, with higher‐grade tumours tending to have reduced nuclear BAG‐1 expression, but there was no association with cytoplasmic BAG‐1. There was also no significant correlation between nuclear or cytoplasmic BAG‐1 expression and oestrogen receptor positivity. Since BAG‐1 may be influenced by hormonal background, the relationship between grade and oestrogen receptor was examined separately in pre‐menopausal and post‐menopausal women. The statistically significant correlation between nuclear BAG‐1 expression and low tumour grade was strong in pre‐menopausal, but not apparent in post‐menopausal women. A statistically significant correlation was observed between cytoplasmic, but not nuclear, BAG‐1 expression and oestrogen receptor status in pre‐menopausal, but not post‐menopausal, women. There was no correlation between BAG‐1 protein expression and RNA, suggesting that important post‐transcriptional mechanisms control BAG‐1 expression in vivo. HSC70 was also detected in the majority (97%) of cases, although expression was not correlated with BAG‐1 levels, oestrogen receptor status or tumour grade. Overall survival in cases with high levels of nuclear BAG‐1 expression was improved, though not significantly. These results are consistent with the hypothesis that BAG‐1 plays an important but variable role in breast cancers developing in pre‐menopausal and post‐menopausal women. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 36 references indexed in Scilit:
- BAG‐1, a negative regulator of Hsp70 chaperone activity, uncouples nucleotide hydrolysis from substrate releaseThe EMBO Journal, 1998
- BAG-1L Protein Enhances Androgen Receptor FunctionJournal of Biological Chemistry, 1998
- Cooperative Interception of Neuronal Apoptosis by BCL‐2 and BAG‐1 Expression: Prevention of Caspase Activation and Reduced Production of Reactive Oxygen SpeciesJournal of Neurochemistry, 1997
- Anti-apoptotic genes, bag-1 and bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycleCytotechnology, 1997
- GrpE‐like regulation of the Hsc70 chaperone by the anti‐apoptotic protein BAG‐1The EMBO Journal, 1997
- Mammalian protein RAP46: an interaction partner and modulator of 70 kDa heat shock proteinsThe EMBO Journal, 1997
- BAG‐1 modulates the chaperone activity of Hsp70/Hsc70The EMBO Journal, 1997
- Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1.Proceedings of the National Academy of Sciences, 1996
- A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning.Proceedings of the National Academy of Sciences, 1995
- Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activityCell, 1995